Fibrosis-targeting drugs may benefit patients with late-stage, metastatic breast canc

[News]

A Massachusetts General Hospital (MGH) research team has found that the overgrowth of connective called fibrosis may block the effectiveness of immunotherapies against metastatic breast cancer.

More... (https://www.news-medical.net/news/20190129/Fibrosis-targeting-drugs-may-benefit-patients-with-late-stage-metastatic-breast-cancer.aspx)